ISRCTN47434271已完成未知
A randomised trial of paclitaxel combined with platinum-based chemotherapy vs conventional platinum-based chemotherapy in the treatment of women with ovarian cancer
Medical Research Council (MRC) (UK)0 个研究点目标入组 802 人开始时间: 2000年4月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 802
研究概览
简要总结
2003 Results article in http://www.ncbi.nlm.nih.gov/pubmed/12826431 results
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Recurrent epithelial ovarian cancer previously treated with chemotherapy
- •2. Treatment-free interval of at least 6 months
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
已完成
3 期
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung CancerLung CancerNCT00193362SCRI Development Innovations, LLC200
已完成
3 期
Paclitaxel plus carboplatin (TC) therapy versus irinotecan plus cisplatin (CPT-P) therapy as a first-line chemotherapy in clear cell ovarian cancerOvarian cancerTopic: National Cancer Research NetworkSubtopic: Gynaecological CancerDisease: OvaryCancerISRCTN52615671Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)667
Unknown
3 期
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerMixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaStage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IA Ovarian Cancer AJCC v6 and v7Stage IA Uterine Sarcoma AJCC v7Stage IB Fallopian Tube Cancer AJCC v6 and v7Stage IB Ovarian Cancer AJCC v6 and v7Stage IB Uterine Sarcoma AJCC v7Stage IC Fallopian Tube Cancer AJCC v6 and v7Stage IC Ovarian Cancer AJCC v6 and v7Stage IC Uterine Sarcoma AJCC v7Stage II Ovarian Cancer AJCC v6 and v7Stage IIA Fallopian Tube Cancer AJCC v6 and v7Stage IIA Ovarian Cancer AJCC V6 and v7Stage IIA Uterine Sarcoma AJCC v7Stage IIB Fallopian Tube Cancer AJCC v6 and v7Stage IIB Ovarian Cancer AJCC v6 and v7Stage IIB Uterine Sarcoma AJCC v7Stage IIC Fallopian Tube Cancer AJCC v6 and v7Stage IIC Ovarian Cancer AJCC v6 and v7Stage IIIA Fallopian Tube Cancer AJCC v7Stage IIIA Ovarian Cancer AJCC v6 and v7Stage IIIA Primary Peritoneal Cancer AJCC v7Stage IIIA Uterine Sarcoma AJCC v7Stage IIIB Fallopian Tube Cancer AJCC v7Stage IIIB Ovarian Cancer AJCC v6 and v7Stage IIIB Primary Peritoneal Cancer AJCC v7Stage IIIB Uterine Sarcoma AJCC v7Stage IIIC Fallopian Tube Cancer AJCC v7Stage IIIC Ovarian Cancer AJCC v6 and v7Stage IIIC Primary Peritoneal Cancer AJCC v7Stage IIIC Uterine Sarcoma AJCC v7Stage IV Fallopian Tube Cancer AJCC v6 and v7Stage IV Ovarian Cancer AJCC v6 and v7Stage IV Primary Peritoneal Cancer AJCC v7Stage IVA Uterine Sarcoma AJCC v7Stage IVB Uterine Sarcoma AJCC v7Uterine CarcinosarcomaNCT00954174GOG Foundation637
招募中
3 期
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast CancerMetastatic Breast Cancer (MBC)NCT06143553Shanghai Yizhong Pharmaceutical Co., Ltd.168
已完成
3 期
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)Uterine Cervical NeoplasmsNCT00295789Haruhiko Fukuda253